Access Clinical Trials, Inc. — Nashville, Tennessee

Access Clinical Trials, Inc. is a clinical research site located in Nashville, Tennessee, United States 37203-6502.

Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.

Access Clinical Trials, Inc. has participated in 12 clinical trials with 4 currently active.

Therapeutic areas: Tourette Disorder, Acute Treatment of Migraine, Postmenopausal Symptoms.

Sponsors: Emalex Biosciences Inc., Pfizer, Noven Therapeutics.

Sponsor Feasibility Report

Trust Score: 76/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Access Clinical Trials, Inc.?

Access Clinical Trials, Inc. has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Access Clinical Trials, Inc. conducted?

Access Clinical Trials, Inc. has 12 clinical trials on record, with 4 currently active. Their work covers Tourette Disorder, Acute Treatment of Migraine, Postmenopausal Symptoms.

Is Access Clinical Trials, Inc. accredited by Crixeo Health?

Yes — Access Clinical Trials, Inc. holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Access Clinical Trials, Inc.?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.